International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news

US patent granted for estimating bone density and fracture risk from X-rays

The United States Patent and Trademark Office granted US 11,737,704, "Systems and methods for approximating bone mineral density and fracture risk using single energy x-rays," to 16 Bit. Inventors: Mark Cicero, Alexander Bilbily and Daniel Eftekhari.

The patent, filed in July 2020 with priority to July 2019, covers methods for estimating bone mineral density and predicting fracture risk from standard single-energy X-rays with neural networks, the technology behind Rho. Rho’s authorized use is to flag possible low bone mineral density. Counterparts were filed in Canada, Europe and Israel.

A continuation, US 12,186,092, was granted on January 7, 2025.